Dammam, Saudi Arabia — Mouwasat Medical H1 2025 profit rose 18.4% to SAR 384 million, up from SAR 324 million in the same period last year. Growing patient volumes drove the increase, along with better contract terms and lower financing and zakat costs, according to the company’s filing on Tadawul.
Mouwasat Medical Posts SAR 384M H1 2025 Profit on Revenue, Cost Gains
Revenue for the first half climbed 10.4% to SAR 1.56 billion. Gross profit grew 7.7% to SAR 703.6 million while operating profit increased 12.2% to SAR 416.7 million. Earnings per share rose to SAR 1.92, compared to SAR 1.62 in H1 2024.
The main drivers were higher patient volumes and reduced impairment, financing, and tax expenses.
Q2 Profit Up Year-on-Year, Down Quarter-on-Quarter
In Q2 2025, Mouwasat reported a net profit of SAR 186.97 million, representing a 22.4% year-over-year increase. However, profit fell 5.1% from Q1, due to higher administrative costs and lower other income. This came despite a 4.2% increase in revenue from the previous quarter.
Q2 revenue reached SAR 796.35 million, marking a 15.4% rise from Q2 2024.
Margin Management and Financial Stability
Total comprehensive income matched net profit for both Q2 and H1. Shareholders’ equity held steady at SAR 3.55 billion. Cost savings from debt repayment and tax efficiency supported profitability.
What This Means for Investors
- Revenue strength: Growth in both outpatient and inpatient services boosts top-line results.
- Efficiency gains: Lower costs and better financial leverage improve margins.
- Stable outlook: Consistent performance confirms strong demand for healthcare.
- Transparency: Clean financial disclosures support investor confidence.
THE SAUDI STANDARD’S VIEW: Mouwasat’s H1 Performance Validates Healthcare Sector Strength
Mouwasat Medical H1 2025 profit of SAR 384 million reflects the growing strength of Saudi Arabia’s private healthcare sector. The company’s double-digit growth highlights strong demand, efficient operations, and alignment with national healthcare goals under Vision 2030.
Rising revenue—driven by increased patient visits—shows trust in private providers and confirms the sector’s maturity. Mouwasat also cut financing and tax costs, which helped lift profits. This demonstrates strong financial planning and effective cost control in a service-intensive industry.
Earnings per share improved, while Q2 spending on operations rose slightly, suggesting Mouwasat is investing carefully in growth. The stable equity figure points to ongoing reinvestment in its service capacity.
As Saudi Arabia advances with its health system reforms, Mouwasat’s results demonstrate that private firms can deliver both strong returns and reliable services. The company’s financial health shows the effectiveness of policies designed to support a world-class, accessible healthcare system.
Related Reading
• Browse the latest Saudi investment news and telecom sector developments
• Explore medical sector earnings and H1 performance of Tadawul-listed hospitals
